check_circleStudy Completed

Pityriasis versicolor

BAY H 4502 cream 2.5% with two different treatment schedules in Pityriasis versicolor

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

N/A
  • -

  • -

Trial summary

Enrollment Goal
60
Trial Dates
January 1988 - June 1988
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Mycospor/Canesten Extra (Bifonazole, BAYH4502)
Accepts Healthy Volunteer
N/A

Trial design

Efficacy and tolerability of BAY H 4502 cream 2.5% with two different treatment schedules in Pityriasis versicolor
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A